Les analogues du GLP-1 et les doubles analogues GIP/GLP-1 : risques associés au mésusage et à l’utilisation hors indication pour la perte de poids

Imported from official source

The FAMHP has been alerted to cases of misuse and off-label use of GLP-1 analogues and GIP/GLP-1 dual analogues, particularly for the purpose of weight loss. Here are a few reminders about the proper use of these medicines. …

This version

Version
1 of 1
Recorded
October 20, 2026 10:32
Change
Initial
Content hash
25b8d49790767c55e32e28457b97b22d
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.